The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Why oh why, share holders see some reward coming through and then the company dump another 90000 shares on the market, in another revenue generating exercise . With the obvious consequence of share price collapse. Expect the share price to be back down to 20p on the 9th December. Not the way to treat long suffering investors.
A couple years ago RMS seemed to have a plan, as to exactly where they were going, now it seems totally speculative , PR has lost huge amounts of money i would imagine . Facemasks is such an extreme lurch into the unknown for RMS, They obviously thought they could make a quick buck before the vaccine comes out. But for a product not yet in manufacture they are desperately short of time. Once these vaccines are being administered there will be no need for face masks.
Lots of selling going on here, although they bought a face mask company, with most major countries around the world now sitting on a successful vaccine there simply isn't the need for this face mask, and it yet needs to come into production. 6 months to late i fear.. for RMS its back to the drawing board i am afraid.
Unfortunately with the AIM index there is not as much regulation as with any other index, companies whether good /bad can be broken purely on sentiment alone. It is a gamble to invest rather than on fact. I personalty would like to see the regulation tightened up, to protect not only the investors but the companies as well. Of coarse there will always be those boards of companies that see the Aim market of lining there own pockets via way of share holders instead of the performance of there company. And that is a good reason to improve the regulation of the Aim market.
I hope MTPH pulls through because i'm convinced there is some excellent work being done to improve peoples health. But its a risky business & i'm afraid many smaller medical research companies fail before getting there drugs licence .
Another issuing of shares on AIM, this time for employees of the company, but you can't get away from the fact that the share price will become even more diluted on a downward trajectory.For long suffering investors the wait for some kind of reward for their investment in the company seems as far away as ever. We can only sit and hope the the company knows something we don't.
Unfortunately , large losses in the last six months , cash will run short very quickly if things don't get turned around quickly. Certainly need some positive news on how these trials are going.
Folks , lets not forget we are over 200% down on 16 days ago, a rise to 50/60p ps , is no consolation to the good folks that invested in this company at 87p only days ago. Lets hope over time they get rewarded too because this company is massively undervalued with the tech they have on board. I would like to MTPH relist at some point on the FT350 instead of AIM, as it would be a lot less volatile
Large losses across the pond now, 30% decline in share price.
What happened gatto, everything went down fast instead, :-(( Sometimes i guess the stock markets are a law to themselves. Hold tight everybody is gonna be a rollercoaster of a day
At last true recognition of the companies worth as collaboration with the big American pharmaceutical companies gathers pace, I have said if before, the technology here is revolutionary. Not just in terms of the public health but with it the billions of dollars of revenue for the worlds best pharmaceuticals . This share price still looks cheap, a buy out or take over I believe is inevitable at some point.
TB selling all his shareholding , has he left the company
This is a typical example of why AIM now needs more regulation, it's like the wild west on here, companies & directors behave without much or any thought of the share holder , who without there investing these companies would not exist.. In some cases its outright fraud , do we ever see prosecutions? no .. not in the UK anyway. Which is a soft touch on most financial regulation matters .
Fully funded & granted the technology here may be worth billions, but a company that has laid off most there staff ? Surely isn't much of a company left to sell?
The technology at hand here is worth billions if brought to market. Heavily undervalued at this sp.
Without GyroMetric RMS doesn't have a business. Does it !!!! We,re listened to TB push the case for 18 months with regards to GyroMetric & it's revolutionary system only to dump it at a drop of a hat. I do feel we as investors have been lead up the garden path again. How do you trust these directors and maintain faith in them.
Disappointing news this morning after strong share price gains, hence the collapse towards the 200 mark again. Revenue down prediction for next trading year has to be a worry going forward. Much now rests on strong post Xmas trading figures for any chance of reaching that target price of 300 anything beyond that now looks un- achievable in the next 18 months.
This is fantastic news folks, massive upside due here, lets remember its only 18 months since the share price was around 119. Huge market and revenue potential in China.
Sad to see another fund raising so soon after the last. Decided to sell after unfortunately a 50% loss after 4 years. I'm sure there is a lot of good work being done, but with the 2nd fund raising in less than a year I can't see anything other than the share price tanking. It also concerns me that a fund raising now would mean there still some way off any news at year end financials of breaking even, let alone profit. One to watch . But for me not to be involved in any longer until I see the value hold in the share price.
Worrying times, as stocks tumble it makes it much more difficult for the company to raise any capital in the future, capital they will need to fund acusisions to grow. Desparatly need genuine news. Not just talk of positive meetings. Actions always speak louder than words. If the share price continues to slide like this the company unfortunately could run outa time.
Serious slide going on with this share price. Not surprising given that there has been no RNS or official news which was expected after the share capitalisation. One can only ussume there is no news to give . Especially with regards to Aviva, I geusse we are now looking at Sept for official figures to see how far the company has moved on, or not as the case may be. My concern is , with lack of news , the share price will end up back where we were , with a much diluted holding.